期刊文献+

非霍奇金淋巴瘤患者血清胰岛素样生长因子-1及其结合蛋白-3表达水平的初步观察

Observation on the expressions of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in non-Hodgkin's lymphoma
下载PDF
导出
摘要 目的:探讨非霍奇金淋巴瘤(NHL)患者血清胰岛素样生长因子-1(IGF-1)及其结合蛋白-3(IGFBP-3)表达水平及其临床意义。方法:选择28例诊断初发NHL患者(淋巴瘤组)及28例健康志愿者(对照组),化学发光法测定血清IGF-1及IGFBP-3水平并计算IGF-1/IGFBP-3值,分析组间的差异。结果:血清IGF-1及IGFBP-3水平淋巴瘤组显著低于正常对照组(均P<0.01);IGF-1/IGFBP-3淋巴瘤组与正常对照组差异无统计学意义(P>0.05);不同亚型的淋巴瘤组的血清IGF-1、IGFBP-3水平及IGF-1/IGFBP-3比值的差异均未达到统计学意义(P>0.05)。结论:NHL患者血清IGF-1及IGFBP-3水平明显降低,可能与NHL相关。IGF-1/IGFBP-3比值与NHL无明显相关性,IGF-1及IGFBP-3水平与NHL的分型无明显相关。 Objective:To investigate the expressions of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with non-Hodgkin's lymphoma (NHL) and its clinical significance.Methods:Twenty-eight cases with newly diagnosed NHL and 28 cases of healthy volunteers were involved in the study.Serum levels of IGF-1 and IGFBP-3 were determined by the method of chemical luminescence,and ratio of IGF-1/IGFBP-3 was counted.The differences were compared between two groups.Results:Serum levels of IGF-1 and IGFBP-3 were significantly lower in NHL group than those in control group (P0.01),but there was no difference in the ratio of IGF-I/IGFBP-3 between two groups (P0.05);and there were no differences in serum levels of IGF-1,IGFBP-3 and the ratio of IGF-1/IGFBP-3 among different types of non-Hodgkin's lymphoma (P0.05).Conclusions:Serum levels of IGF-1 and IGFBP-3 significantly decreased in patients with NHL,and might relate with NHL.The ratio of IGF-1/IGFBP-3 has no obvious correlation with NHL.Serum levels of IGF-1 and IGFBP-3 have no obvious correlation with types of NHL.
出处 《内科急危重症杂志》 2012年第2期94-95,共2页 Journal of Critical Care In Internal Medicine
关键词 胰岛素样生长因子-1 胰岛素样生长因子结合蛋白-3 非霍奇金淋巴瘤 Insulin-like growth factor-1 Insulin-like growth factor binding protein-3 Non-Hodgkin's lymphoma
  • 相关文献

参考文献8

  • 1林桐榆.高危弥漫大B细胞淋巴瘤的诊断和治疗进展[J].肿瘤预防与治疗,2008,21(1):1-7. 被引量:12
  • 2王黎,沈志祥.弥漫大B细胞淋巴瘤的分子诊断及治疗进展[J].内科急危重症杂志,2011,17(5):257-259. 被引量:7
  • 3Grimberg A,Cohen P.Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.J Cell Physiol,2000,183(1):1-9.
  • 4Wu Y,Yakar S,Zhao L,et al.Circulating insulin-like growth factor levels regulate colon cancer growth and metastasis.Cancer Res,2002,62(4):1030.
  • 5Oliver SE,Gunnell D,Donowan J,et al.Screen-detected prostare cancer and the insulin-like growth factor axis.Results of a population based case-control s tudy.Int J cancer,2004,108(6):887.
  • 6Vishwamitra D,Shi P,Wilson D,et al.Expression and effects of inhi-bition of IGF-IR tyrosine kinase in mantle cell lymphoma.Haemato-logica,USA,2011(VN).
  • 7Firth SM,Baxter RC.Cellular Actions of the Insulin-Like Growth Fac-tor Binding Proteins.Endocrine Reviews,2002,23(6):824-854.
  • 8Gui YT,Murphy LJ.Insulin-like growth factor(IGF)-binding pro-tein-3(IGFBP-3)binds to fibronectin(FN):demonstration of IGF-I/IGFBP-3/FN ternary complexes in human plasma.J Clin Endocrinol Metab,2001,86(5):2104-2110.

二级参考文献18

  • 1Jaffe ES. The 2008 WHO classification of lymphomas: implica tions for clinical practice and translational research. Hematology Am Soc Hematol Educ Program, 2009:523.
  • 2Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profi ling. Nature, 2000,403:503.
  • 3Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med, 2002,346 : 1937.
  • 4Stevenson F, Sahota S, Zhu D, et al. lnsight into the origin and clonal history of B-cell tumors as revealed by analysis of immuno- globulin variable region genes. Immunol Rev, 1998,162 : 247.
  • 5Mittrucker HW, Matsuyama T, Grossman A, et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science, 1997,275:540.
  • 6Lossos IS. Molecular pathogenesis of diffuse large B-cell lymphoma. J Clin Oncol, 2005,23:6351.
  • 7Shaffer AL, Yu X, He Y, et al. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity, 2000,13:199.
  • 8Davis RE, Brown KD, Siebenlist U, et al. Constitutive nuclear factor kappaB activity is required for survival of activated B celllike diffuse large B cell lymphoma cells. J Exp Med, 2001,194: 1861.
  • 9Smith PG, Wang F~ Wilkinson KN, et al. The phosphodiester ase PDE4B limits cAMP associated PI3K/AKT dependent apoptosis in diffuse large B cell lymphoma. Blood, 2005,105:308.
  • 10Lu X, Nechushtan H, Ding F, et al. Distinct Ⅱ-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B cell-like diffuse large cell lym- phomas. Blood, 2005,105 : 2924.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部